We showed that an increased SALL4 expression in endometrial cancer was significantly associated with lymph node metastasis (P = 0.048), tumor stage (P = 0.001), myometrial invasion (P = 0.007) and poor survival (Fig 1C). This evidence concerns the gene SALL4 and endometrial cancer.